REFERENCES
1. Welschmeyer A, Berke GS. An updated review of the epidemiological
factors associated with recurrent respiratory papillomatosis
[Review]. Laryngoscope Investigative Otolaryngology. 2021
April;6(2):226-233. PubMed PMID: 2010280128.
2. Larson DA, Derkay CS. Epidemiology of recurrent respiratory
papillomatosis. APMIS : acta pathologica, microbiologica, et
immunologica Scandinavica. 2010 Jun;118(6-7):450-4. doi:
10.1111/j.1600-0463.2010.02619.x. PubMed PMID: 20553527; eng.
3. Woo SH, Chung P-S, Sangjoon L. Treatment of Recurrent Respiratory
Papillomatosis Using Laser and Available Adjuvant Therapies. Medical
Lasers. 2020 2020;9(2):126-133. doi: 10.25289/ml.2020.9.2.126. PubMed
PMID: KJD:ART002662788.
4. Manley C, Hutchinson C, Mahajan A, et al. Treatment of Recurrent
Respiratory Papillomatosis: Case Series and Review of Technique.
Surgical Technology International-International Developments in Surgery
and Surgical Research. 2021 Jun;38. PubMed PMID: WOS:000661729000016.
5. Papaspyrou G, Schick B, Papaspyrou S, et al. Retrospective analysis
of laser vs other therapeutic modalities for laryngeal papillomatosis:
European multicenter study. Journal of Buon. 2016
Sep-Oct;21(5):1274-1278. PubMed PMID: WOS:000388782200031.
6. Tran MN, Galt L, Bashirzadeh F. Recurrent respiratory papillomatosis:
the role of cidofovir. Respirol Case Rep. 2018 Nov;6(8):e00371. doi:
10.1002/rcr2.371. PubMed PMID: 30302253; PubMed Central PMCID:
PMCPMC6167758. eng.
7. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of
recurrent respiratory papillomatosis - An alternative to the carbon
dioxide laser. Archives of Otolaryngology-Head & Neck Surgery. 2002
Apr;128(4):425-428. doi: 10.1001/archotol.128.4.425. PubMed PMID:
WOS:000174855200013.
8. Murono S, Nakanishi Y, Tsuji A, et al. Trends in the management of
recurrent respiratory papillomatosis in Japan. Auris Nasus Larynx. 2015
Jun;42(3):218-220. doi: 10.1016/j.anl.2014.10.006. PubMed PMID:
WOS:000355031300007.
9. Papaioannou VA, Lux A, Voigt-Zimmermann S, et al. Treatment outcomes
of recurrent respiratory papillomatosis: Retrospective analysis of
juvenile and adult cases [Article]. HNO. 2018;66:7-15. doi:
10.1007/s00106-017-0378-0. PubMed Central PMCID: PMC28840259. English.
10. Lawlor C, Balakrishnan K, Bottero S, et al. International Pediatric
Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory
papillomatosis consensus recommendations. International Journal of
Pediatric Otorhinolaryngology. 2020 Jan;128. doi:
10.1016/j.ijporl.2019.109697. PubMed PMID: WOS:000508742100011.
11. Derkay CS, Hester RP, Burke B, et al. Analysis of a staging
assessment system for prediction of surgical interval in recurrent
respiratory papillomatosis. International Journal of Pediatric
Otorhinolaryngology. 2004 Dec;68(12):1493-1498. doi:
10.1016/j.ijporl.2004.06.007. PubMed PMID: WOS:000225323400002.
12. Patel N, Rowe M, Tunkel D. Treatment of recurrent respiratory
papillomatosis in children with the microdebrider. Annals of Otology
Rhinology and Laryngology. 2003 Jan;112(1):7-10. doi:
10.1177/000348940311200102. PubMed PMID: WOS:000180442300002.
13. Hung WC, Lo WC, Fang KM, et al. Longitudinal Voice Outcomes
Following Serial Potassium Titanyl Phosphate Laser Procedures for
Recurrent Respiratory Papillomatosis. The Annals of otology, rhinology,
and laryngology. 2021 Apr;130(4):363-369. doi: 10.1177/0003489420950374.
PubMed PMID: 32847376; eng.
14. Rees CJ, Tridico TI, Kirse DJ. Expanding applications for the
microdebrider in pediatric endoscopic airway surgery.
Otolaryngology-Head and Neck Surgery. 2005 Oct;133(4):509-513. doi:
10.1016/j.otohns.2005.06.029. PubMed PMID: WOS:000232461000006.
15. Dedo HH, Yu KCY. CO2 laser treatment in 244 patients with
respiratory papillomas. The Laryngoscope. 2001 Sep;111(9):1639-1644.
doi: 10.1097/00005537-200109000-00028. PubMed PMID: WOS:000170987500028.
16. Hock K, Kennedy A, Howell R, et al. Surgery and Adjuvant Therapy
Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis.
The Laryngoscope. 2022. doi: 10.1002/lary.30042. PubMed PMID:
WOS:000750938400001.
17. Burns JA, Friedman AD, Lutch MJ, et al. Value and utility of 532
nanometre pulsed potassium-titanyl-phosphate laser in endoscopic
laryngeal surgery. Journal of Laryngology and Otology. 2010
Apr;124(4):407-411. doi: 10.1017/s0022215109991824. PubMed PMID:
WOS:000276923300012.
18. Preuss SF, Klussmann JP, Jungehulsing M, et al. Long-term results of
surgical treatment for recurrent respiratory papillomatosis. Acta
oto-laryngologica. 2007 Nov;127(11):1196-201. doi:
10.1080/00016480701200350. PubMed PMID: 17851940; eng.
19. Araki K, Tomifuji M, Uno K, et al. Feasibility of transnasal
flexible carbon dioxide laser surgery for laryngopharyngeal lesions.
Auris Nasus Larynx. 2019 Oct;46(5):772-778. doi:
10.1016/j.anl.2019.01.008. PubMed PMID: 30765273; eng.
20. Miller AJ, Gardner GM. In-Office vs. Operating Room Procedures for
Recurrent Respiratory Papillomatosis. Ent-Ear Nose & Throat Journal.
2019 Dec. doi: 10.1177/0145561319889538. PubMed PMID:
WOS:000680807300001.